Universal Beteiligungs und Servicegesellschaft mbH Lowers Stock Position in Addus HomeCare Corporation $ADUS

Universal Beteiligungs und Servicegesellschaft mbH lessened its holdings in shares of Addus HomeCare Corporation (NASDAQ:ADUS) by 91.1% during the third quarter, HoldingsChannel reports. The fund owned 1,769 shares of the company’s stock after selling 18,191 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Addus HomeCare were worth $209,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. State of Wyoming acquired a new position in shares of Addus HomeCare during the 2nd quarter worth $47,000. Raymond James Financial Inc. acquired a new stake in shares of Addus HomeCare in the second quarter valued at about $61,000. Blue Trust Inc. boosted its holdings in Addus HomeCare by 42.9% during the third quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $63,000 after buying an additional 161 shares in the last quarter. CWM LLC grew its position in Addus HomeCare by 25.3% during the second quarter. CWM LLC now owns 554 shares of the company’s stock worth $64,000 after buying an additional 112 shares during the period. Finally, EverSource Wealth Advisors LLC grew its position in Addus HomeCare by 560.0% during the second quarter. EverSource Wealth Advisors LLC now owns 561 shares of the company’s stock worth $65,000 after buying an additional 476 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, EVP Darby Anderson sold 20,000 shares of Addus HomeCare stock in a transaction that occurred on Wednesday, November 19th. The shares were sold at an average price of $109.00, for a total transaction of $2,180,000.00. Following the transaction, the executive vice president directly owned 44,144 shares of the company’s stock, valued at $4,811,696. The trade was a 31.18% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Over the last quarter, insiders sold 20,316 shares of company stock valued at $2,215,998. Insiders own 4.50% of the company’s stock.

Addus HomeCare Stock Performance

NASDAQ ADUS opened at $105.60 on Thursday. The business’s 50-day moving average price is $111.00 and its 200 day moving average price is $112.89. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.14. Addus HomeCare Corporation has a twelve month low of $88.96 and a twelve month high of $124.43. The company has a market capitalization of $1.95 billion, a PE ratio of 22.61, a price-to-earnings-growth ratio of 1.28 and a beta of 0.91.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings results on Monday, November 3rd. The company reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.53 by $0.03. The company had revenue of $362.30 million for the quarter, compared to the consensus estimate of $354.48 million. Addus HomeCare had a net margin of 6.36% and a return on equity of 9.53%. Addus HomeCare’s revenue was up 25.0% on a year-over-year basis. During the same quarter last year, the firm posted $1.30 earnings per share. On average, research analysts predict that Addus HomeCare Corporation will post 4.59 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. BMO Capital Markets began coverage on Addus HomeCare in a research note on Thursday, November 13th. They set a “market perform” rating and a $120.00 price target on the stock. Weiss Ratings reiterated a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, January 21st. Wall Street Zen lowered Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Sunday, January 25th. TD Cowen reaffirmed a “buy” rating on shares of Addus HomeCare in a research note on Wednesday, November 5th. Finally, Royal Bank Of Canada boosted their price objective on shares of Addus HomeCare from $134.00 to $139.00 and gave the stock an “outperform” rating in a research report on Friday, November 7th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $135.44.

Addus HomeCare Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.